Are there any therapeutic approaches targeting MOG?
Therapeutic strategies targeting MOG are being explored, particularly in autoimmune demyelinating diseases. These include the development of monoclonal antibodies to neutralize anti-MOG antibodies, immunomodulatory drugs, and tolerization therapies aimed at reducing the immune response against MOG. Understanding the precise role of MOG in these diseases is crucial for designing effective treatments.
